Cervical cancer: open trials in Canada

• NCT06760819

  A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

  Trial Treatment · Phase 2 · Bayer

  Queen Elizabeth II Health Sciences Centre | Oncology, Halifax · Research Institute of the McGill University Health Centre | Women Health's Research Unit, Montreal · Princess Margaret Cancer Centre | Medical Oncology and Hematology, Toronto

  Registry updated 2026-11-04

• NCT07216703

  A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  Arthur J.E. Child Comprehensive Cancer Centre ( Site 0609), Calgary · Cross Cancer Institute ( Site 0614), Edmonton · Nova Scotia Cancer Centre ( Site 0617), Halifax · London Health Sciences Centre ( Site 0613), London · McGill University Health Centre ( Site 0602), Montreal · Centre Hospitalier de l'Université de Montréal ( Site 0616), Montreal · Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus ( Site 0611), Québec · CIUSSS de l Estrie Centre Hospitalier Universitaire de Sherbrooke ( Site 0604), Sherbrooke · Sunnybrook Research Institute ( Site 0605), Toronto · Princess Margaret Cancer Centre ( Site 0601), Toronto

  Registry updated 2026-10-29

• NCT07516210

  Adaptive Radiotherapy for Safe Hypofractionation

  Trial Treatment · Phase 2 · Centre hospitalier de l'Université de Montréal (CHUM)

  Centre Hospitalier de l'Université de Montréal, Montreal

  Registry updated 2026-10-29

• NCT06172478

  A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  Trial Treatment · Phase 2 · Daiichi Sankyo

  Cross Cancer Institute, Edmonton · Sunnybrook Research Institute, Toronto · Princess Margaret Cancer Centre, Toronto · BC Cancer - Vancouver, Vancouver

  Registry updated 2026-10-26

• NCT06079671

  Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)

  Trial Treatment · Phase 3 · AstraZeneca

  Hamilton · London · Montreal · Ste-Foy · Toronto

  Registry updated 2026-09-30

• NCT06535607

  Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors

  Trial Treatment · Phase 2 · AstraZeneca

  Edmonton · Montreal

  Registry updated 2026-09-11

• NCT04895709

  A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

  Trial Treatment · Phase 1/2 · Bristol-Myers Squibb

  Cross Cancer Institute, Edmonton · Hamilton Health Sciences-Juravinski Cancer Centre, Hamilton · Centre Hospitalier de luniversite de Montreal, Montreal · Ottawa · Toronto · Vancouver

  Registry updated 2026-08-17

• NCT05592626

  A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

  Trial Treatment · Phase 1/2 · Marengo Therapeutics, Inc.

  Princess Margaret Cancer Centre, Toronto

  Registry updated 2026-08-11

• NCT04831580

  A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer

  Trial Treatment · GOG Foundation

  McGill University Health Centre Glen Site, Montreal · Centre Hospitalier de l'Université de Montréal, Montreal · Princess Margaret Cancer Center, Toronto

  Registry updated 2026-07-30

• NCT03853915

  FDG-PET and Circulating HPV in Patients With Cervical Cancer Treated With Definitive Chemoradiation (II)

  Trial Treatment · University Health Network, Toronto

  University Health Network, The Princess Margaret, Toronto

  Registry updated 2026-03-05

• NCT05941507

  A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

  Trial Treatment · Phase 1/2 · LigaChem Biosciences, Inc.

  Princess Margaret Cancer Centre, Toronto

  Registry updated 2025-09-24

• NCT04016389

  FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery

  Trial Treatment · Phase 2 · University Health Network, Toronto

  L'Hôtel-Dieu de Québec, Québec · Princess Margaret Cancer Centre, Toronto · Sunnybrook Health Sciences Centre, Toronto

  Registry updated 2025-08-12

• NCT03061435

  Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer.

  Trial Treatment · Dr. Danielle Vicus

  Odette Cancer Centre, Toronto

  Registry updated 2025-05-16

• NCT04583254

  Hypofractionated External-beam RadiOtherapy for Intact Cervical Cancer (HEROICC-Trial): A Feasibility Study

  Trial Treatment · Phase 2 · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

  BC Cancer - Kelowna, Kelowna · London Health Sciences Centre - London Regional Cancer Program, London · Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto

  Registry updated 2023-05-10

All Cervical cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error